Lanlan Wei

541 citations
16 papers · 253 indexed · h-index 7
Topics
SARS-CoV-2 and COVID-19 Research (4 papers)COVID-19 Clinical Research Studies (4 papers)Long-Term Effects of COVID-19 (3 papers)
Partner nations
ChinaUnited StatesChile

In The Last Decade

Lanlan Wei

16 papers receiving 247 citations

Peers

Lanlan Wei
Comparison fields: 5 of 64
  • Infectious Diseases 135
  • Molecular Biology 58
  • Neurology 42
  • Epidemiology 42
  • Genetics 37
Replace Manabu Kitagaki with:
Manabu Kitagaki Japan
Weibiao Zeng China
Feng‐Zeng Li China
Yile Dai United States
Sofía Bernal‐Silva Mexico
Han-Ping Huang China
Adolfo Firpo‐Betancourt United States
Ayman Al Jurdi United States
Eleonora Tartaglia Italy
Salahudeen Mohamed Haja Mohideen Singapore
Lanlan Wei relative to Manabu Kitagaki Japan Manabu Kitagaki's profile →
Citations per field
00.5×
Manabu Kitagaki · 1×
Citations per year

Countries citing papers authored by Lanlan Wei

Since Specialization
Citations

This map shows the geographic impact of Lanlan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Wei more than expected).

Fields of papers citing papers by Lanlan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Wei. The network helps show where Lanlan Wei may publish in the future.

Co-authorship network of co-authors of Lanlan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Wei. A scholar is included among the top collaborators of Lanlan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Wei. Lanlan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 6
2 3
3 2
4 1
5 6
6 26
7 4
8 17
9 13
10 42
11 3
12 81
13 1
14 2
15
[The effect of high-pass filter circuit on accurate measurement of ST-segment].
2
16 44

About Lanlan Wei

Lanlan Wei is a scholar working on Infectious Diseases, Otorhinolaryngology and Cancer Research, having authored 16 papers that have together received 253 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Infectious Diseases (135 citations), Modeling and Simulation (17 citations) and Obstetrics and Gynecology (22 citations). Lanlan Wei has collaborated with scholars based in China, United States and Chile. Frequent co-authors include Zheng Zhang, Xuejiao Liao, Haiyan Wang, Lei Liu, Juanjuan Zhao, Mingzhao Xing, Haiping Wang, Hongxi Gu, Fengmin Zhang and Catharina Lavebratt. Their work appears in journals such as Clinical Infectious Diseases, Frontiers in Immunology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026